Prolonged duration of response to infliximab in early pediatric Crohn's disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 33, Issue SUPPL. 1, 2001, Pages

  Kugathasan, S ^a  

^a Midwest Athletes Against Childhood Cancer Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; TIOGUANINE;

ADOLESCENT; ADULT; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CROHN DISEASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0034785611     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200109001-00007     Document Type: Conference Paper

References (17)

1. Epidemiology and the natural course of inflammatory bowel disease
2. Practice guidelines: Management of Crohn's disease in adults
3. Inflammatory bowel disease in pediatric and adolescent patients
4. Disease activity courses in a regional cohort of Crohn's disease patients
5. Frequency of glucocorticoid resistance and dependency in Crohn's disease
6. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45Rbhi CD4+ T cells
7. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
8. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
9. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
10. Infliximab for the treatment of fistulas in patients with Crohn's disease
11. A multicenter study of infliximab (anti-TNFα antibody) in the treatment of children with active Crohn's disease
12. Use of infliximab in the treatment of Crohn's disease in children and adolescents
13. Treatment of pediatric Crohn's disease (CD) with anti-tumor necrosis factor alpha chimeric monoclonal antibody (infliximab)
14. Clonal T cell cytokine secretion is modulated in mucosa of children with recent onset but not chronic inflammatory bowel disease
15. Distinct mucosal T cell responses to IL-12 in early and late stages of inflammatory bowel diseases
16. 6-Mercaptopurine (6MP) + prednisone therapy for newly diagnosed pediatric Crohn's disease (CD): A prospective, randomized multicenter placebocontrolled clinical trial
17. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease